Doctor Tymon Pol
Uppsala University, Uppsala (Sweden)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Multiplex screening for biomarkers associated with subsequent heart failure hospitalisation in patients with atrial fibrillation: insights from the ARISTOTLE trial
Event: ESC Congress 2023
Topic: Pathophysiology
Session: Pathophysiological studies in heart failure
Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Atrial fibrillation obesity
ESC 365 is supported by
